AAAAAA

   
Results: 1-18 |
Results: 18
Detailed characterization of 12 supernumerary ring chromosomes using micro-FISH and search for uniparental disomy
Authors: Anderlid, BM Sahlen, S Schoumans, J Holmberg, E Ahsgren, I Mortier, G Speleman, F Blennow, E
Citation: Bm. Anderlid et al., Detailed characterization of 12 supernumerary ring chromosomes using micro-FISH and search for uniparental disomy, AM J MED G, 99(3), 2001, pp. 223-233
The use of intragenic polymorphisms in determination of the genomic relevance of whole-exon deletions in MLH1 and MSH2
Authors: Liu, T Holmberg, E Lindblom, A
Citation: T. Liu et al., The use of intragenic polymorphisms in determination of the genomic relevance of whole-exon deletions in MLH1 and MSH2, CLIN GENET, 59(3), 2001, pp. 201-202
Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients
Authors: Casassus, P Gibson, J Joshua, DE Matthews, J Diaz, JC Gertz, MA Kyle, R Leong, T Oken, MM Fritz, E Ludwig, H Corrado, C Lastiri, F Peest, D Grosbois, B Vela-Ojeda, J Avvisati, G Mandelli, F Petrucci, MT Capnist, G Child, JA Drayson, MT Dunn, J MacLennan, I Mellstedt, H Osterborg, A Rodjer, S Turesson, I Westin, J Bergsagel, D Browman, GP Shustik, C Zee, B Hjorth, M Holmberg, E Rodjer, S Turesson, I Westin, J Alison, R Clarke, M Elphinstone, P Evans, V Gray, R Hicks, C James, S MacKinnon, L Peto, R Richards, S Wheatley, K Blade, J Fontanillas, M San Miguel, J Aitchison, R Newland, AC Cunningham, D Malpas, J Powles, RL Montuoro, A Jacobson, J Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy
Authors: Holmberg, E Holm, LE Lundell, M Mattsson, A Wallgren, A Karlsson, P
Citation: E. Holmberg et al., Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy, BR J CANC, 85(3), 2001, pp. 362-366
Genetic epidemiology of glioma
Authors: Malmer, B Iselius, L Holmberg, E Collins, A Henriksson, R Gronberg, H
Citation: B. Malmer et al., Genetic epidemiology of glioma, BR J CANC, 84(3), 2001, pp. 429-434
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland
Authors: Sarantaus, L Huusko, P Eerola, H Launonen, V Vehmanen, P Rapakko, K Gillanders, E Syrjakoski, K Kainu, T Vahteristo, P Krahe, R Paakkonen, K Hartikainen, J Blomqvist, C Lopponen, T Holli, K Ryynanen, M Butzow, R Borg, A Arver, BW Holmberg, E Mannermaa, A Kere, J Kallioniemi, OP Winqvist, R Nevanlinna, H
Citation: L. Sarantaus et al., Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland, EUR J HUM G, 8(10), 2000, pp. 757-763
Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period
Authors: Holmang, S Hedelin, H Anderstrom, C Holmberg, E Johansson, SL
Citation: S. Holmang et al., Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period, SC J UROL N, 34(2), 2000, pp. 95-101
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus
Authors: Kainu, T Juo, SHH Desper, R Schaffer, AA Gillanders, E Rozenblum, E Freas-Lutz, D Weaver, D Stephan, D Bailey-Wilson, J Kallioniemi, OP Tirkkonen, M Syrjakoski, K Kuukasjarvi, T Koivisto, P Karhu, R Holli, K Arason, A Johannesdottir, G Bergthorsson, JT Johannsdottir, H Egilsson, V Barkardottir, RB Johannsson, O Haraldsson, K Sandberg, T Holmberg, E Gronberg, H Olsson, H Borg, A Vehmanen, P Eerola, H Heikkila, P Pyrhonen, S Nevanlinna, H
Citation: T. Kainu et al., Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus, P NAS US, 97(17), 2000, pp. 9603-9608
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study
Authors: Lenhoff, S Hjorth, M Holmberg, E Turesson, I Westin, J Nielsen, JL Wisloff, F Brinch, L Carlson, K Carlson, M Dahl, IM Gimsing, P Hippe, E Johnsen, H Lamvik, J Lofvenberg, E Nesthus, I Rodjer, S
Citation: S. Lenhoff et al., Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study, BLOOD, 95(1), 2000, pp. 7-11
Survival in conventionally treated younger (< 60 years) multiple myeloma patients: no improvement during two decades
Authors: Hjorth, M Holmberg, E Rodjer, S Turesson, I Westin, J Wisloff, F
Citation: M. Hjorth et al., Survival in conventionally treated younger (< 60 years) multiple myeloma patients: no improvement during two decades, EUR J HAEMA, 62(4), 1999, pp. 271-277
Efficacy of pamidronate in breast cancer with bone metastases: A randomized, double-blind placebo-controlled multicenter study
Authors: Hultborn, R Gundersen, S Ryden, S Holmberg, E Carstensen, J Wallgren, UB Killany, S Andreassen, L Carlsson, G Fahl, N Hatschek, T Sommer, HH Hessman, Y Hornmark-Stenstam, B Johnsborg, S Klepp, R Laino, R Niklasson, LG Rudenstam, CM Sundbeck, A Soderberg, M Tejler, G
Citation: R. Hultborn et al., Efficacy of pamidronate in breast cancer with bone metastases: A randomized, double-blind placebo-controlled multicenter study, ANTICANC R, 19(4C), 1999, pp. 3383-3392
Breast cancer risk after radiotherapy in infancy: A pooled analysis of twoSwedish cohorts of 17,202 infants
Authors: Lundell, M Mattsson, A Karlsson, P Holmberg, E Gustafsson, A Holm, LE
Citation: M. Lundell et al., Breast cancer risk after radiotherapy in infancy: A pooled analysis of twoSwedish cohorts of 17,202 infants, RADIAT RES, 151(5), 1999, pp. 626-632
Recurrence and progression in low grade papillary urothelial tumors
Authors: Holmang, S Hedelin, H Anderstrom, C Holmberg, E Busch, C Johansson, SL
Citation: S. Holmang et al., Recurrence and progression in low grade papillary urothelial tumors, J UROL, 162(3), 1999, pp. 702-707
Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors
Authors: Turesson, I Abildgaard, N Ahlgren, T Dahl, IM Holmberg, E Hjorth, M Nielsen, JL Oden, A Seidel, C Waage, A Westin, J Wisloff, F
Citation: I. Turesson et al., Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors, BR J HAEM, 106(4), 1999, pp. 1005-1012
Serum hyaluronan in patients with multiple myeloma: Correlation with survival and Ig concentration
Authors: Dahl, IMS Turesson, I Holmberg, E Lilja, K
Citation: Ims. Dahl et al., Serum hyaluronan in patients with multiple myeloma: Correlation with survival and Ig concentration, BLOOD, 93(12), 1999, pp. 4144-4148
Soft tissue sarcoma after treatment for breast cancer - A Swedish population-based study
Authors: Karlsson, P Holmberg, E Samuelsson, A Johansson, KA Wallgren, A
Citation: P. Karlsson et al., Soft tissue sarcoma after treatment for breast cancer - A Swedish population-based study, EUR J CANC, 34(13), 1998, pp. 2068-2075
MSH2 codon 322 Gly to Asp seems not to confer an increased risk for colorectal cancer susceptibility
Authors: Liu, T Stathopoulos, P Lindblom, P Rubio, C Arver, BW Iselius, L Holmberg, E Gronberg, H Lindblom, A
Citation: T. Liu et al., MSH2 codon 322 Gly to Asp seems not to confer an increased risk for colorectal cancer susceptibility, EUR J CANC, 34(12), 1998, pp. 1981-1981
Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials
Authors: Pasquali, S Maqueo, JD Vela, J Kyle, RA Leong, T Fritz, E Suciu, S Palva, IP Oivanen, T Corrado, C Lastiri, FJ Peest, D Kildahl-Andersen, O Maniatis, A Alison, R Clarke, M Evans, V Gray, R Greaves, E Hall, E Hicks, C James, S Peto, R Richards, S Sinclair, D Tooth, A Wheatley, K Avvisati, G Boccadoro, M Bugliosi, R Mandelli, F Petrucci, MT Pileri, A Tribalto, M Alexanian, R Delasalle, KB Child, J Dunn, J MacLennan, I Milligan, D Mellstedt, H Osterborg, A Hjorth, M Holmberg, E Rodjer, S Westin, J Kamiya, O Shimizu, K Bergsagel, DE Shustik, C Hippe, E Kjaersgaard, E Turesson, I Westin, J Riccardi, A Ucci, G Blade, J Fontanillas, M De Rosa, L Montuoro, A Bartolucci, AA Omura, GA Stagg, M Salmon, S Tangen, C Jacobs, P Wood, L Levy, LM
Citation: S. Pasquali et al., Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials, J CL ONCOL, 16(12), 1998, pp. 3832-3842
Risultati: 1-18 |